HUMA 1.70 ▼ -3.95% Live Trading Data - Stocknear

Humacyte Inc.

NASDAQ: HUMA · Real-Time Price · USD
1.70
-0.07 (-3.95%)
At close: Oct 16, 2025, 3:59 PM
1.71
0.59%
After-hours: Oct 16, 2025, 07:55 PM EDT
-3.95%
Bid 1.67
Market Cap 269.39M
Revenue (ttm) 8.05M
Net Income (ttm) -58.66M
EPS (ttm) -0.47
PE Ratio (ttm) -3.62
Forward PE -5.11
Analyst Buy
Dividends n/a
Ask 1.76
Volume 4,238,691
Avg. Volume (20D) 5,471,853
Open 1.77
Previous Close 1.77
Day's Range 1.67 - 1.79
52-Week Range 1.15 - 6.77
Beta 1.89
Ex-Dividend Date n/a

About HUMA

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol HUMA
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for HUMA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
Humacyte Inc. is scheduled to release its earnings on Nov 7, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-33.47%
Humacyte shares are trading lower after the compan... Unlock content with Pro Subscription
1 week ago
+18.1%
Humacyte shares are trading higher after the company announced the company published long-term results for Ukranian patients treated in real-world combat setting with Symvess in Military Medicine.